Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV002267591 | SCV002549721 | likely pathogenic | Hereditary spastic paraplegia 50 | 2022-07-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002267591 | SCV005804116 | pathogenic | Hereditary spastic paraplegia 50 | 2024-11-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val48Serfs*33) in the AP4M1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP4M1 are known to be pathogenic (PMID: 24700674, 25496299, 25558065). This variant is present in population databases (rs764326593, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with AP4M1-related conditions (PMID: 37486637). ClinVar contains an entry for this variant (Variation ID: 1697248). For these reasons, this variant has been classified as Pathogenic. |